SBRI: Vaccine development for potential epidemic diseases stage 1

The UK Vaccine Network (UKVN) have opened a new research call for the development of vaccines and vaccine technologies for diseases with the potential to cause an epidemic in low and middle income countries; this work will be delivered by Innovate UK. The call is now open, and will close on the 12th of July.

Overview of call:

• Organisations can apply for a share of up to £25 million in funding to develop vaccine candidates and technologies targeting the UKVN’s priority pathogens. Proposals can address any part of the development pathway including pre-clinical, non-clinical development, manufacturing process design and phase 1 clinical trials.
• Projects will last for 24 months, with a maximum value of £2 million per project.
• This call is for stage 1 of a potential two stage competition. The decision to proceed with a stage 2 competition will depend on the outcomes from stage 1 and assessment of a separate application into a subsequent stage 2 competition.
• Lead applicants can be an organisation of any size; work alone or with others from business, research organisations, research and technology organisations or the third sector as subcontractors
• This competition is open to applicants from any country.

Projects must:

• Have vaccine candidates, platforms and technologies addressing a UKVN priority pathogen or Disease X
• Be Official Development Assistance (ODA) compliant, meaning projects may be carried out in high-income countries, but the primary aim of the research must be to improve the health, welfare or economic development of countries on the OECD Development Assistance Committee (DAC) list

MORE INFORMATION